Dr. Howard L. Kaufman, MD

Dr. Kaufman practices at Massachusetts Eye and Ear in Boston, Massachusetts, part of Mass General Brigham.

Dr. Kaufman's NPI, 1376627109, was assigned on October 25, 2006. Dr. Kaufman graduated from Logan College of Chiropractic in 1986. Dr. Kaufman holds Massachusetts license 72588.

Dr. Kaufman's primary practice is Massachusetts Eye and Ear, at 243 Charles Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 523-7900.

Dr. Kaufman's primary practice is Massachusetts Eye and Ear in Boston, Massachusetts, part of Mass General Brigham. Dr. Kaufman is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Kaufman to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaufman practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Kaufman's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Kaufman is licensed in Massachusetts.

CMS data shows 397 Medicare services from Dr. Kaufman across 5 procedure codes in 2024, for 148 Medicare patients. Medicare paid $19,669 for them.

CMS counts 148 Medicare patients who saw Dr. Kaufman in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaufman's median patient age at 78, with 32% women.

In 2024, Dr. Kaufman wrote 59 Medicare Part D claims for 15 patients. 73% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $200 in total drug cost. In 2023, CMS named 39 claims across 3 drugs.

Dr. Kaufman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaufman as offering telehealth.

Dmand AI links 160 papers to Dr. Kaufman, published from 2010 to 2025. 2017 was the busiest year, with 14. The most frequent topics are Immunotherapy, Melanoma and Skin Neoplasms. Dr. Kaufman has published most often in J Immunother Cancer. Dr. Kaufman's most frequent co-authors are Ann Willman Silk, MD, Janice M. Mehnert and Brendan David Curti, MD.

Dmand AI links Dr. Kaufman to 4 clinical trials. Conditions studied include Melanoma, Carcinoma, Renal Cell and Neoplasm Metastasis.

CMS Open Payments shows 75 general payments to Dr. Kaufman from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. EMD Serono, Inc. paid the most, $33,706. It also lists 5 research payments totaling $2,207 from 2022 to 2023.

Dr. Kaufman graduated from Logan College of Chiropractic in 1986.